New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Body Fat Without Loss of Muscle Mass The natural GLP-1 activator is clinically shown to support fat loss, including visceral fat reduction, while preserving lean muscle AUCKLAND, New Zealand, July 23, 2026 --(BUSINESS WIRE)--Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, announces today the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurb's effectiveness in weight loss and muscle preservation
BPC 157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability
USA 110 , 52115216 (2013) Tom Burnley, B ., Afonine, P
Highly competent, courteous and professional service
And we love, love, love collaborating with practitioners